Rapport Therapeutics ($RAPP) Insider Trading & Smart Money Activity
Rapport Therapeutics, Inc. ($RAPP) has 4 insider trades and 2 analyst ratings on file. In the last 12 months on the open market, no insider bought and 2 insiders sold ($561.69K), net -$561.69K.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 2
- Net insider $ (12 mo)
- -$561.69K
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 2
RAPP insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 2 · $418.42K | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 2 · $143.27K | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All RAPP insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Ceesay AbrahamChief Executive Officer | Sell (Open-market sale) 10b5-1 | 1.15K sh | $35.17K | -8.2% | — | |||||
| Insider | Ceesay AbrahamChief Executive Officer | Sell (Open-market sale) 10b5-1 | 3.38K sh | $108.11K | -6.9% | — | |||||
| Insider | Gault CherylChief Operating Officer | Sell (Open-market sale) 10b5-1 | 10K sh | $331.86K | -8.2% | — | |||||
| Insider | Ceesay AbrahamChief Executive Officer | Sell (Open-market sale) 10b5-1 | 2.21K sh | $86.57K | -1.6% | — | |||||
| Analyst | Leerink Partners | Reiterates to buy | PT $52 | -1.5% | +1.7% | Read | |||||
| Analyst | Leerink Partners | Reiterates to buy | PT $52 | -1.5% | +1.7% | Read |
1W / 1M / 6M = how RAPP moved from the trade or filing date.
Insider trading in RAPP: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Ceesay Abraham | Chief Executive Officer | 3 | -$229.84K | Oct 7, 2026 | |
| Gault Cheryl | Chief Operating Officer | 1 | -$331.86K | Sep 30, 2026 |
Analyst ratings on RAPP
Frequently asked questions
Are RAPP insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 2 insiders made 4 open-market sales worth $561.69K, a net -$561.69K.
What is the latest insider trade in RAPP?
Ceesay Abraham, Chief Executive Officer filed a sell (open-market sale) of 1.15K sh worth $35.17K on Oct 7, 2026.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.